BIONET Therapeutics Corp. (TPEX:7808)
Taiwan
· Delayed Price · Currency is TWD 48.20
-1.25 (-2.53%)
At close: Mar 9, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 3.37 billion as of March 9, 2026. Its market cap has decreased by -16.90% in one year.
Market Cap
3.37B
Enterprise Value
2.24B
Revenue
105.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.20
Market Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 3.37B, a decrease of -11.56%. That is a compound annual growth rate of -9.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.46B | -12.01% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Libo Pharma | 3.46B |
| Merdury Biopharmaceutical | 3.47B |
| Richmond International Travel & Tours Co.,Ltd | 3.47B |
| Tian Zheng International Precision Machinery | 3.44B |
| Zen Voce | 3.49B |
| CastleNet Technology | 3.49B |
| Celxpert Energy | 3.49B |
| Shine-On BioMedical | 3.43B |